Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mini implant aims to lower eye pressure during cataract surgery

NCT ID NCT07354009

Recruiting now Disease control Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a small device called iStent that is placed in the eye during cataract surgery to help lower pressure in people with open-angle glaucoma. Sixty adults with both glaucoma and cataracts will be enrolled. The goal is to see if the iStent is safe and effective at reducing eye pressure compared to cataract surgery alone.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
iStent (a tiny implant placed in the eye during cataract surgery)
What this could lead to
If it works, this could offer a way to better control eye pressure in glaucoma patients who also need cataract surgery, potentially reducing the need for eye drops.
What could go wrong
This is a small, early-phase study with only 60 participants, so results may not apply to everyone. The implant may not lower pressure enough or could cause side effects like inflammation or implant movement.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract glaucoma open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Eye Center, the 2nd Affiliated Hospital, Medical College of Zhejiang University

    RECRUITING

    Hangzhou, China

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.